Brain HealthClinical TrialPaywall

Flavonoid Supplement Shows Promise for Cognitive Function in Elderly Adults

Italian researchers test plant-based compounds for brain health and quality of life in aging adults with promising early results.

Saturday, March 28, 2026 0 views
Published in ClinicalTrials.gov
Clinical trial visualization: Flavonoid Supplement Shows Promise for Cognitive Function in Elderly Adults

Summary

Italian researchers completed a clinical trial testing whether Altemor, a dietary supplement containing micronized diosmin, hesperidin, and herbal extracts, could improve cognitive function and quality of life in elderly adults. The 36-participant study focused on older adults experiencing cognitive impairment and age-related debility. Researchers measured cognitive performance, balance, fatigue levels, and various quality of life indicators over several months. The supplement contains flavonoids, plant compounds known for antioxidant and neuroprotective properties that support blood circulation and may protect against age-related cognitive decline. This research addresses the growing need for interventions supporting healthy aging as global populations age rapidly.

Detailed Summary

A completed clinical trial from Italy's Fondazione Policlinico Universitario Agostino Gemelli investigated whether targeted nutritional supplementation could combat age-related cognitive decline in elderly adults. The study enrolled 36 participants experiencing cognitive impairment and age-related debility to test Altemor, a supplement containing micronized diosmin, hesperidin, and herbal extracts.

The trial ran from May 2024 to February 2025, measuring cognitive function, balance, fatigue, and quality of life domains. The intervention focused on flavonoids, plant compounds with demonstrated antioxidant, neuroprotective, and circulation-supporting properties. These phytochemicals represent over 5,000 compounds that epidemiological studies link to reduced cardiovascular, metabolic, and inflammatory disease risk.

The research addresses critical global health needs as populations age rapidly. By 2050, adults over 80 will triple to 426 million worldwide, with Italy representing the world's second-oldest population. Age-related cognitive changes often lead to frailty, falls, and disability, making nutritional interventions increasingly important.

While specific results await publication, the completed status suggests researchers successfully gathered data on whether this flavonoid combination could meaningfully impact cognitive performance and daily functioning in older adults. The study builds on limited existing research examining hesperidin and proanthocyanidins' effects on motor, cognitive, and functional aspects of aging, potentially offering evidence-based support for plant-compound supplementation in healthy aging strategies.

Key Findings

  • 36 elderly participants completed testing of flavonoid supplement for cognitive function
  • Study measured cognitive performance, balance, fatigue and quality of life indicators
  • Supplement contained micronized diosmin, hesperidin and circulation-supporting herbal extracts
  • Trial addresses growing need for interventions supporting healthy cognitive aging
  • Research completed successfully with results pending publication

Methodology

This was a completed interventional trial enrolling 36 elderly participants with cognitive impairment over approximately 9 months. The study tested a specific flavonoid supplement formulation against multiple outcome measures including cognitive function, balance, and quality of life domains.

Study Limitations

Small sample size of 36 participants limits generalizability to broader elderly populations. Study design details and control group information are not specified, and actual results have not yet been published or peer-reviewed.

Enjoyed this summary?

Get the latest longevity research delivered to your inbox every week.